Thus, importantly, the protective effect of SGK1 inhibition on AF inducibility in this model is unlikely to derive from hemodynamic effects or effects on LA pressure secondary to the beneficial effects of SGK1 on ventricular remodeling, but rather suggest a primary beneficial effect of SGK1 inhibition on AF pathogenesis. The gene discussed is SGK1; the disease is atrial fibrillation.